Eli Lilly and

LLY · NYSE

$1,283.66+$43.32 (+3.49%)TodayMarket closed · Oct 20, 7:59 PM ET

Prev close $1,240.34

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The company is headquartered in Indianapolis, Indiana and currently employs 50,000 full-time employees. The firm manufacture and distribute its products through facilities in the United States, including Puerto Rico, and in Europe and Asia. The Company’s products are sold in approximately 90 countries. Its Cardiometabolic Health products Basaglar; Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, and others; Humulin, Humulin 70/30, and others; Jardiance; Mounjaro; Trulicity; Zepbound, and others. Its oncology products include Cyramza, Erbitux, Tyvyt, Verzenio, Retevmo, Jaypirca, and others. Its immunology products include Ebglyss, Olumiant, Omvoh, and Taltz. Its neuroscience products include Emgality and Kisunla. Its LillyDirect, a direct-to-patient digital health care platform, provides delivery of select Lilly medicines dispensed by third-party pharmacies to patients.

Employees: 50,000
Headquarters: Indianapolis, Indiana
Listed: Jul 9, 1970
Sector: Health Care
Industry: Pharmaceuticals
Website: lilly.com

Leadership

Eli Lilly and executives
Name	Title	Since	Age
David Ricks	—	2012	57
Lucas Montarce	—	—	47
Eric Dozier	—	—	58
Diogo Rau	—	—	50
Daniel Skovronsky	—	—	51
Anat Hakim	—	—	55
Edgardo Hernandez	—	—	50
Patrik Jonsson	—	—	58
Melissa Seymour	—	—	55
Jacob Van Naarden	—	—	40
Ilya Yuffa	—	—	50
Juan Luciano	—	—	63
Ralph Alvarez	—	—	69
Katherine Baicker	—	—	53
Carolyn Bertozzi	—	—	59
J. Erik Fyrwald	—	—	65
Mary Hedley	—	—	62
Jamere Jackson	—	—	56
Kimberly Johnson	—	—	52
William Kaelin	—	—	67
Jon Moeller	—	—	61
Gabrielle Sulzberger	—	—	65

Revenue by product and region

Fiscal year ended Dec 31, 2025: $65.18B total revenue

By product

Net product revenue$60.96B93.5%
Collaboration and other revenue$4.22B6.5%

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

Eli Lilly and suppliers and customers
Company	Relationship	Country	Correlation
Myriad Genetics MYGN	Supplier and customer	—	0.89
OptimizeRx OPRX	Supplier	—	0.89
FUJIFILM Holdings	Supplier	—	0.88
Alexandria Real Estate ARE	Supplier	—	0.86
Nippon Kayaku Co., Ltd.	Customer	—	0.85
Merck MRK.DE	Customer	—	0.85
Cambridge Cognition Hldgs COG.L	Supplier	—	0.85
Harvard Bioscience HBIO	Supplier	—	0.84
Dnnlly Fincl Sol-WI DFIN	Supplier	—	0.84
Saudi Pharmaceutical Industries and Medical Appliances Corporation	Supplier	—	0.83

Similar companies

Companies in the same industry as Eli Lilly and

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.